TEPLONEER

pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of rheumatological diseases; pharmaceutical preparations for the prevention and treatment of Multiple Sclerosis; pharmaceutical preparations for use in organ and tissue transplantation; pharmaceutical preparations for the prevention and treatment of Graft versus Host Disease; pharmaceutical preparations for the prevention and treatment of Narcolepsy; pharmaceutical preparations for the prevention and treatment of Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED); pharmaceutical preparations for the prevention and treatment of Uveitis; pharmaceutical preparations for the prevention and treatment of Vitiligo; pharmaceutical preparations for the prevention and treatment of T cell Lymphoma and T cell Leukemia; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders and asthma